Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) Margin of Safety % (DCF Earnings Based): N/A (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920729 Guangdong Winsun Bio Pharmaceutical Co Ltd BJSE:920729
74 GF Score
Price ¥7.00
GF Value ¥5.67
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Guangdong Winsun Bio Pharmaceutical Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Guangdong Winsun Bio Pharmaceutical Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


BJSE:920729 vs VRTX, REGN, RVMD: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Guangdong Winsun Bio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Winsun Bio Pharmaceutical Co Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong Winsun Bio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Guangdong Winsun Bio Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) falls into.


BJSE:920729
74GF Score
Guangdong Winsun Bio Pharmaceutical Co Ltd BJSE:920729
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Winsun Bio Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥7.00 is trading 23.5% above its estimated GF Value™ of ¥5.67. GuruFocus considers Guangdong Winsun Bio Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for BJSE:920729:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥5.67 vs. price of ¥7.00 (23.5% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920729 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangdong Winsun Bio Pharmaceutical Co Business Description

Address No. 35 Tianyuan West Road, Huangpu District, Guangdong Province, Guangzhou City, CHN, 511356
Guangdong Winsun Bio Pharmaceutical Co Ltd is involved in the field of veterinary biological products. It is an enterprise integrating research and development, production, sales, and service of veterinary biological products. It engages in the production of embryotoxin live vaccines, cytotoxic live vaccines, bacterial live vaccines, avian influenza inactivated vaccines, cytotoxic inactivated vaccines, embryotoxin inactivated vaccines, bacterial inactivated vaccines, swine fever live vaccines (rabbit source); veterinary use of Biological products.
74GF Score

Get the complete analysis for BJSE:920729

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.00
Price
¥5.67
GF Value